Tandem Diabetes (TNDM) Misses Q1 EPS by 4c, Affirms Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tandem Diabetes Care Reports First Quarter 2015 Financial Results
April 30, 2015 4:15 PM EDTSAN DIEGO, April 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today reported its financial results for the quarter ended March 31, 2015.
In comparing the first quarter of 2015 to the same period of 2014:
Sales grew 53 percent to $12.3 million from $8.1 million t:slim Pump shipments grew 44 percent to 2,487 pumps from 1,723 pumps"Our investment in resources to build the foundation of our business is driving year-over-year revenue growth and improving... More
